TILADE Drug Patent Profile
✉ Email this page to a colleague
When do Tilade patents expire, and what generic alternatives are available?
Tilade is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TILADE?
- What are the global sales for TILADE?
- What is Average Wholesale Price for TILADE?
Summary for TILADE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Clinical Trials: | 1 |
Patent Applications: | 3,572 |
DailyMed Link: | TILADE at DailyMed |
Recent Clinical Trials for TILADE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
CAMP Steering Committee | Phase 3 |
Johns Hopkins Bloomberg School of Public Health | Phase 3 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
US Patents and Regulatory Information for TILADE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | TILADE | nedocromil sodium | SOLUTION;INHALATION | 020750-001 | Oct 1, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TILADE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TILADE
See the table below for patents covering TILADE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 2563105 | COMPOSITIONS POUR LES SOINS DES VOIES RESPIRATOIRES | ⤷ Sign Up |
Spain | 8707222 | PROCEDIMIENTO PARA LA OBTENCION DEL 9-ETIL-4,6-DIOXO-10-PROPIL-6,9-DIHIDRO-4H-PIRANO(3,2-G)QUINOLINA-2,8-DICARBOXILATO DE DIETILO (Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate) | ⤷ Sign Up |
Japan | H01199909 | PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRANOQUINOLINE DERIVATIVE | ⤷ Sign Up |
Luxembourg | 79579 | ⤷ Sign Up | |
United Kingdom | 2022078 | ⤷ Sign Up | |
Netherlands | 184896 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |